Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes

Pain Physician

Volumn 16, Issue 2, 2013, Pages

  Kou, Zhen Zhen ^a   Li, Chun Yu ^a   Tang, Jun ^a   Hu, Jia Chen ^a   Qu, Juan ^a,b   Liao, Yong Hui ^a   Wu, Sheng Xi ^a   Li, Hui ^a   Li, Yun Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Insulin receptor; Insulin receptor substance 1; JAK2; Mouse; Painful diabetic neuropathy; STAT3

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; JANUS KINASE 2; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERALGESIA; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NEUROBLASTOMA CELL; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAINFUL DIABETIC NEUROPATHY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; JANUS KINASE 2; MICE; MICE, OBESE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SPINAL CORD; STAT3 TRANSCRIPTION FACTOR;

EID: 84875323821     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Ziegler D. Painful diabetic neuropathy: Treatment and future aspects. Diabetes Metab Res Rev 2008; 24: S52-S57.
2. Obrosova IG. Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments. Neurotherapeutics 2009; 6:638-647.
3. Fischer TZ, Waxman SG. Neuropathic pain in diabetes--evidence for a central mechanism. Nat Rev Neurol 2010; 6:462-466.
4. Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova IG. The leptin-deficient (ob/ob) mouse: A new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 2006; 55:3335-3343.
5. Daousi C, Benbow SJ, Woodward A, MacFarlane IA. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med 2006; 23:1021-1024.
6. Eaton SE, Harris ND, Rajbhandari SM, Greenwood P, Wilkinson ID, Ward JD, Griffiths PD, Tesfaye S. Spinal-cord involvement in diabetic peripheral neuropathy. Lancet 2001; 358:35-36.
7. Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neu-rosci 2010; 11:823-836.
8. Baskin DG, Figlewicz DP, Woods SC, Porte D, Dorsa DM. Insulin in the brain. Annu Rev Physiol 1987; 49:335-347.
9. Unger JW, Livingston JN, Moss AM. Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects. Prog Neu-robiol 1991; 36:343-362.
10. Greenwood CE, Winocur G. Glucose treatment reduces memory deficits in young adult rats fed high-fat diets. Neu-robiol Learn Mem 2001; 75:179-189.
11. Lam CK, Chari M, Lam TK. CNS regulation of glucose homeostasis. Physiology (Bethesda) 2009; 24:159-170.
12. Bates SH, Myers MG. The role of leptin-->STAT3 signaling in neuroendocrine function: An integrative perspective. J Mol Med (Berl) 2004; 82:12-20.
13. Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 2004; 59:305-331.
14. Fukushima A, Loh K, Galic S, Fam B, Shields B, Wiede F, Tremblay ML, Watt MJ, Andrikopoulos S, Tiganis T. T-cell protein tyrosine phosphatase attenuates STAT3 and insulin signaling in the liver to regulate gluconeogenesis. Diabetes 2010; 59:1906-1914.
15. Ortiz-Munoz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, Sanz A, Blanco J, Mezzano S, Ortiz A, Egido J, Gomez-Guerrero C. Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol 2010; 21:763-772.
16. Marrero MB, Lucas R, Salet C, Hauser TA, Mazurov A, Lippiello PM, Bencherif M. An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes. The Journal of Pharmacology and Experimental Therapeutics 2010; 332:173-180.
17. Nicolas CS, Peineau S, Amici M, Csaba Z, Fafouri A, Javalet C, Collett VJ, Hil-debrandt L, Seaton G, Choi SL, Sim SE, Bradley C, Lee K, Zhuo M, Kaang BK, Gressens P, Dournaud P, Fitzjohn SM, Bortolotto ZA, Cho K, Collingridge GL. The Jak/STAT pathway is involved in syn-aptic plasticity. Neuron2012; 73:374-390.
18. Dziennis S, Alkayed NJ. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Reviews in the Neurosciences 2008; 19:341-361.
19. Ge SN, Ma YF, Hioki H, Wei YY, Kaneko T, Mizuno N, Gao GD, Li JL. Coexpres-sion of VGLUT1 and VGLUT2 in tri-geminothalamic projection neurons in the principal sensory trigeminal nucleus of the rat. J Comp Neurol 2010; 518:3149-3168.
20. Brussee V, Guo G, Dong Y, Cheng C, Martinez JA, Smith D, Glazner GW, Fernyhough P, Zochodne DW. Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model. Diabetes 2008; 57:1664-1673.
21. Corkey BE. Banting lecture 2011: Hy-perinsulinemia: Cause or consequence? Diabetes 2012; 61:4-13.
22. Folli F, Bonfanti L, Renard E, Kahn CR, Merighi A. Insulin receptor sub-strate-1 (IRS-1) distribution in the rat central nervous system. J Neurosci 1994; 14:6412-6422.
23. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372:186-190.
24. Carvalheira JB, Torsoni MA, Ueno M, Amaral ME, Araujo EP, Velloso LA, Gon-tijo JA, Saad MJ. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obesity Research 2005; 13:48-57.
25. Benomar Y, Roy AF, Aubourg A, Djiane J, Taouis M. Cross down-regulation of leptin and insulin receptor expression and signalling in a human neuronal cell line. Biochem J 2005; 388:929-939.
26. Dominguez E, Rivat C, Pommier B, Mauborgne A, Pohl M. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. Journal of Neurochemistry 2008; 107:50-60.
27. Tsuda M, Kohro Y, Yano T, Tsujikawa T, Kitano J, Tozaki-Saitoh H, Koyanagi S, Ohdo S, Ji RR, Salter MW, Inoue K. JAK-STAT3 pathway regulates spinal as-trocyte proliferation and neuropathic pain maintenance in rats. Brain 2011; 134:1127-1139.
28. Lim G, Wang S, Zhang Y, Tian Y, Mao J. Spinal leptin contributes to the patho-genesis of neuropathic pain in rodents. J Clin Invest 2009; 119:295-304.
29. Lund IV, Hu Y, Raol YH, Benham RS, Faris R, Russek SJ, Brooks-Kayal AR. BDNF selectively regulates GABAA receptor transcription by activation of the JAK/STAT pathway. Sci Signal 2008; 1:ra9.
30. Kim YD, Kim YH, Cho YM, Kim DK, Ahn SW, Lee JM, Chanda D, Shong M, Lee CH, Choi HS. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models. Diabetologia 2012.;55:1482-1494.
31. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998; 93:385-395.
32. Li C, Friedman JM. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proceedings of the National Academy of Sciences of the United States of America 1999; 96:9677-9682.
33. Valentini L, Wirth EK, Schweizer U, Hengstermann S, Schaper L, Koernicke T, Dietz E, Norman K, Buning C, Win-klhofer-Roob BM, Lochs H, Ockenga J. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009; 25:172-181.
34. Krogh-Madsen R, Moller K, Dela F, Kron-borg G, Jauffred S, Pedersen BK. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. American Journal of Physiology Endocrinology and Metabolism 2004; 286:E766-E772.
35. Fernandez-Real JM, Pickup JC. Innate immunity, insulin resistance and type 2 diabetes. Diabetologia 2012; 55:273-278.
36. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sciences 2000; 67:291-300.
37. Pradhan AD, Manson JE, Rifai N, Bur-ing JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334.
38. Vanhanen M, Koivisto K, Kuusisto J, Mykkanen L, Helkala EL, Hanninen T, Riekkinen P Sr, Soininen H, Laak-so M. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 1998; 21:398-402.
39. Araki T, Nawa H, Neel BG. Tyrosyl phos-phorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. The Journal of Biological Chemistry 2003; 278:41677-41684.
40. Schweizerhof M, Stosser S, Kurejova M, Njoo C, Gangadharan V, Agarwal N, Schmelz M, Bali KK, Michalski CW, Brugger S, Dickenson A, Simone DA, Kuner R. Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain. Nature Medicine 2009; 15:802-807.